The Elusive Progenitor Cell in Cardiac Regeneration: Slip Slidin' Away

Circulation Research

Volumn 120, Issue 2, 2017, Pages 400-406

  Cai, Chen Leng ^a   Molkentin, Jeffery D ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

consensus; myocardium; myocytes cardiac; regeneration; stem cells

Indexed keywords

STEM CELL FACTOR RECEPTOR;

ALLELE; CARDIAC MUSCLE CELL; CARDIAC STEM CELL; CELL PROLIFERATION; CYTOLOGY; HEART INFARCTION; HEART TISSUE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TISSUE REGENERATION; ANIMAL; CELL DIFFERENTIATION; HEART DISEASES; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATION; STEM CELL; STEM CELL TRANSPLANTATION; TRANSPLANTATION; TRENDS;

ANIMALS; CELL DIFFERENTIATION; HEART DISEASES; HUMANS; MYOCYTES, CARDIAC; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 85009875675     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.309710     Document Type: Review

References (54)

1. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-705. doi: 10.1038/35070587.
2. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004;428:668-673. doi: 10.1038/nature02460.
3. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA, Field LJ. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004;428:664-668. doi: 10.1038/nature02446.
4. Anversa P, Kajstura J, Rota M, Leri A. Regenerating new heart with stem cells. J Clin Invest. 2013;123:62-70. doi: 10.1172/JCI63068.
5. Nadal-Ginard B, Ellison GM, Torella D. The cardiac stem cell compartment is indispensable for myocardial cell homeostasis, repair and regeneration in the adult. Stem Cell Res. 2014;13:615-630. doi: 10.1016/j. scr.2014.04.008.
6. van Berlo JH, Molkentin JD. An emerging consensus on cardiac regeneration. Nat Med. 2014;20:1386-1393. doi: 10.1038/nm.3764.
7. Keith MC, Bolli R. String theory of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results. Circ Res. 2015;116:1216-1230. doi: 10.1161/CIRCRESAHA.116.305557.
8. Porrello ER, Mahmoud AI, Simpson E, Hill JA, Richardson JA, Olson EN, Sadek HA. Transient regenerative potential of the neonatal mouse heart. Science. 2011;331:1078-1080. doi: 10.1126/science.1200708.
9. Oberpriller JO, Oberpriller JC. Response of the adult newt ventricle to injury. J Exp Zool. 1974;187:249-253. doi: 10.1002/jez.1401870208.
10. Becker RO, Chapin S, Sherry R. Regeneration of the ventricular myocardium in amphibians. Nature. 1974;248:145-147.
11. Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafish. Science. 2002;298:2188-2190. doi: 10.1126/science.1077857.
12. Kikuchi K, Holdway JE, Werdich AA, Anderson RM, Fang Y, Egnaczyk GF, Evans T, Macrae CA, Stainier DY, Poss KD. Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature. 2010;464:601-605. doi: 10.1038/nature08804.
13. Foglia MJ, Poss KD. Building and re-building the heart by cardiomyocyte proliferation. Development. 2016;143:729-740. doi: 10.1242/dev.132910.
14. Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, Johnson RL, Martin JF. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science. 2011;332:458-461. doi: 10.1126/science.1199010.
15. Mahmoud AI, Kocabas F, Muralidhar SA, Kimura W, Koura AS, Thet S, Porrello ER, Sadek HA. Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature. 2013;497:249-253. doi: 10.1038/nature12054.
16. Szibor M, Pöling J, Warnecke H, Kubin T, Braun T. Remodeling and dedifferentiation of adult cardiomyocytes during disease and regeneration. Cell Mol Life Sci. 2014;71:1907-1916. doi: 10.1007/s00018-013-1535-6.
17. Uygur A, Lee RT. Mechanisms of cardiac regeneration. Dev Cell. 2016;36:362-374. doi: 10.1016/j.devcel.2016.01.018.
18. Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res. 1998;83:15-26.
19. Soonpaa MH, Field LJ. Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am J Physiol. 1997;272:H220-H226.
20. Senyo SE, Steinhauser ML, Pizzimenti CL, Yang VK, Cai L, Wang M, Wu TD, Guerquin-Kern JL, Lechene CP, Lee RT. Mammalian heart renewal by pre-existing cardiomyocytes. Nature. 2013;493:433-436. doi: 10.1038/nature11682.
21. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisén J. Evidence for cardiomyocyte renewal in humans. Science. 2009;324:98-102. doi: 10.1126/science.1164680.
22. Bergmann O, Zdunek S, Felker A, et al. Dynamics of cell generation and turnover in the human heart. Cell. 2015;161:1566-1575. doi: 10.1016/j. cell.2015.05.026.
23. Anversa P, Kajstura J, Rota M, Leri A. Regenerating new heart with stem cells. J Clin Invest. 2013;123:62-70. doi: 10.1172/JCI63068.
24. Saraste A, Pulkki K, Kallajoki M, Heikkilä P, Laine P, Mattila S, Nieminen MS, Parvinen M, Voipio-Pulkki LM. Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest. 1999;29:380-386.
25. Dawn B, Zuba-Surma EK, Abdel-Latif A, Tiwari S, Bolli R. Cardiac stem cell therapy for myocardial regeneration. A clinical perspective. Minerva Cardioangiol. 2005;53:549-564.
26. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763-776.
27. Hesse M, Fleischmann BK, Kotlikoff MI. Concise review: the role of C-kit expressing cells in heart repair at the neonatal and adult stage. Stem Cells. 2014;32:1701-1712. doi: 10.1002/stem.1696.
28. Molkentin JD, Houser SR. Are resident c-Kit+ cardiac stem cells really all that are needed to mend a broken heart? Circ Res. 2013;113:1037-1039. doi: 10.1161/CIRCRESAHA.113.302564.
29. Quijada P, Sussman MA. Making it stick: chasing the optimal stem cells for cardiac regeneration. Expert Rev Cardiovasc Ther. 2014;12:1275-1288. doi: 10.1586/14779072.2014.972941.
30. Nagalingam RS, Safi HA, Czubryt MP. Gaining myocytes or losing fibroblasts: challenges in cardiac fibroblast reprogramming for infarct repair. J Mol Cell Cardiol. 2016;93:108-114. doi: 10.1016/j.yjmcc.2015.11.029.
31. Qian L, Srivastava D. Direct cardiac reprogramming: from developmental biology to cardiac regeneration. Circ Res. 2013;113:915-921. doi: 10.1161/CIRCRESAHA.112.300625.
32. Chong JJ, Yang X, Don CW, et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature. 2014;510:273-277. doi: 10.1038/nature13233.
33. Tang XL, Li Q, Rokosh G, Sanganalmath SK, Chen N, Ou Q, Stowers H, Hunt G, Bolli R. Long-term outcome of administration of c-kit(POS) cardiac progenitor cells after acute myocardial infarction: transplanted cells do not become cardiomyocytes, but structural and functional improvement and proliferation of endogenous cells persist for at least one year. Circ Res. 2016;118:1091-1105. doi: 10.1161/CIRCRESAHA.115.307647.
34. Hong KU, Guo Y, Li QH, Cao P, Al-Maqtari T, Vajravelu BN, Du J, Book MJ, Zhu X, Nong Y, Bhatnagar A, Bolli R. c-kit+ Cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart. PLoS One. 2014;9:e96725. doi: 10.1371/journal.pone.0096725.
35. van Berlo JH, Kanisicak O, Maillet M, Vagnozzi RJ, Karch J, Lin SC, Middleton RC, Marbán E, Molkentin JD. c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature. 2014;509:337-341. doi: 10.1038/nature13309.
36. Wu SM, Fujiwara Y, Cibulsky SM, Clapham DE, Lien CL, Schultheiss TM, Orkin SH. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell. 2006;127:1137-1150. doi: 10.1016/j.cell.2006.10.028.
37. Wallner M, Duran JM, Mohsin S, et al. Acute catecholamine exposure causes reversible myocyte injury without cardiac regeneration. Circ Res. 2016;119:865-879. doi: 10.1161/CIRCRESAHA.116.308687.
38. Nadal-Ginard B, Ellison GM, Torella D. Absence of evidence is not evidence of absence: pitfalls of cre knock-ins in the c-Kit locus. Circ Res. 2014;115:415-418. doi: 10.1161/CIRCRESAHA.114.304676.
39. Sultana N, Zhang L, Yan J, Chen J, Cai W, Razzaque S, Jeong D, Sheng W, Bu L, Xu M, Huang GY, Hajjar RJ, Zhou B, Moon A, Cai CL. Resident c-kit(+) cells in the heart are not cardiac stem cells. Nat Commun. 2015;6:8701. doi: 10.1038/ncomms9701.
40. Liu Q, Yang R, Huang X, Zhang H, He L, Zhang L, Tian X, Nie Y, Hu S, Yan Y, Zhang L, Qiao Z, Wang QD, Lui KO, Zhou B. Genetic lineage tracing identifies in situ Kit-expressing cardiomyocytes. Cell Res. 2016;26:119-130. doi: 10.1038/cr.2015.143.
41. Klein S, Seidler B, Kettenberger A, Sibaev A, Rohn M, Feil R, Allescher HD, Vanderwinden JM, Hofmann F, Schemann M, Rad R, Storr MA, Schmid RM, Schneider G, Saur D. Interstitial cells of Cajal integrate excitatory and inhibitory neurotransmission with intestinal slow-wave activity. Nat Commun. 2013;4:1630. doi: 10.1038/ncomms2626.
42. Hatzistergos KE, Saur D, Seidler B, Balkan W, Breton M, Valasaki K, Takeuchi LM, Landin AM, Khan A, Hare JM. Stimulatory effects of mesenchymal stem cells on cKit+ cardiac stem cells are mediated by SDF1/CXCR4 and SCF/cKit signaling pathways. Circ Res. 2016;119:921-930. doi: 10.1161/CIRCRESAHA.116.309281.
43. Hatzistergos KE, Takeuchi LM, Saur D, Seidler B, Dymecki SM, Mai JJ, White IA, Balkan W, Kanashiro-Takeuchi RM, Schally AV, Hare JM. cKit+ cardiac progenitors of neural crest origin. Proc Natl Acad Sci U S A. 2015;112:13051-13056. doi: 10.1073/pnas.1517201112.
44. Jensen P, Farago AF, Awatramani RB, Scott MM, Deneris ES, Dymecki SM. Redefining the serotonergic system by genetic lineage. Nat Neurosci. 2008;11:417-419. doi: 10.1038/nn2050.
45. Engleka KA, Manderfield LJ, Brust RD, Li L, Cohen A, Dymecki SM, Epstein JA. Islet1 derivatives in the heart are of both neural crest and second heart field origin. Circ Res. 2012;110:922-926. doi: 10.1161/CIRCRESAHA.112.266510.
46. Heger K, Seidler B, Vahl JC, Schwartz C, Kober M, Klein S, Voehringer D, Saur D, Schmidt-Supprian M. CreER(T2) expression from within the c-Kit gene locus allows efficient inducible gene targeting in and ablation of mast cells. Eur J Immunol. 2014;44:296-306. doi: 10.1002/eji.201343731.
47. Zaruba MM, Soonpaa M, Reuter S, Field LJ. Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts. Circulation. 2010;121:1992-2000. doi: 10.1161/CIRCULATIONAHA.109.909093.
48. Jesty SA, Steffey MA, Lee FK, Breitbach M, Hesse M, Reining S, Lee JC, Doran RM, Nikitin AY, Fleischmann BK, Kotlikoff MI. c-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart. Proc Natl Acad Sci U S A. 2012;109:13380-13385. doi: 10.1073/pnas.1208114109.
49. Molkentin JD. Letter by Molkentin regarding article, The absence of evidence is not evidence of absence: the pitfalls of Cre Knock-Ins in the c-Kit Locus. Circ Res. 2014;115:e21-e23. doi: 10.1161/CIRCRESAHA.114.305011.
50. Leri A, Anversa P. Complexity of tracking the fate of adult progenitor cells. Circ Res. 2016;119:1067-1070. doi: 10.1161/CIRCRESAHA.116.309731.
51. Menasché P. Skeletal myoblasts as a therapeutic agent. Prog Cardiovasc Dis. 2007;50:7-17. doi: 10.1016/j.pcad.2007.02.002.
52. Doyle MJ, Maher TJ, Li Q, Garry MG, Sorrentino BP, Martin CM. Abcg2-Labeled cells contribute to different cell populations in the embryonic and adult heart. Stem Cells Dev. 2016;25:277-284. doi: 10.1089/scd.2015.0272.
53. Noseda M, Harada M, McSweeney S, et al. PDGFR? demarcates the cardiogenic clonogenic Sca1+ stem/progenitor cell in adult murine myocardium. Nat Commun. 2015;6:6930. doi: 10.1038/ncomms7930.
54. Zhou B, Honor LB, Ma Q, Oh JH, Lin RZ, Melero-Martin JM, von Gise A, Zhou P, Hu T, He L, Wu KH, Zhang H, Zhang Y, Pu WT. Thymosin beta 4 treatment after myocardial infarction does not reprogram epicardial cells into cardiomyocytes. J Mol Cell Cardiol. 2012;52:43-47. doi: 10.1016/j. yjmcc.2011.08.020.